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Abstract 
Background: Fibroblast growth factors (FGFs) are crucial signaling molecules that direct the development of the 
vertebrate brain. FGF8 gene signaling in particular, may be important for the development of the hypothalamus–
pituitary–adrenal (HPA)-axis. Indeed, newborn Fgf8 hypomorphic mice harbor a major reduction in the number 
of vasopressin (VP) neurons in the paraventricular nucleus (PVN), the central output component of the HPA-axis. 
Additionally, recent studies indicated that adult heterozygous (+/neo) Fgf8 hypomorphic mice exhibit more anxiety-like 
behaviors than wildtype (WT) mice. These studies led us to investigate whether Fgf8 hypomorphy abrogated VP and/
or corticotropin-releasing hormone (CRH) neuronal development in the postnatal day (PN) 21 and adult mouse PVN. 
Furthermore, we studied whether Fgf8 hypomorphy disrupted HPA responsiveness in these mice.
Methods: Using immunohistochemistry, we examined the development of VP and CRH neurons located in the PVN 
of PN 21 and adult Fgf8+/neo mice. Moreover, we used a restraint stress (RS) paradigm and measured corticosterone 
levels with enzyme immunoassays in order to assess HPA axis activation.
Results: The number of VP neurons in the PVN did not differ between WT and Fgf8+/neo mice on PN 21 and in adult-
hood. In contrast, CRH immunoreactivity was much higher in Fgf8+/neo mice than in WT mice on PN 21, this difference 
was no longer shown in adult mice. RS caused a higher increase in corticosterone levels in adult Fgf8+/neo mice than 
in WT mice after 15 min, but no difference was seen after 45 min.
Conclusions: First, Fgf8 hypomorphy did not eliminate VP and CRH neurons in the mouse PVN, but rather disrupted 
the postnatal timing of neuropeptide expression onset in PVN neurons. Second, Fgf8 hypomorphy may, in part, be an 
explanation for affective disorders involving hyperactivity of the HPA axis, such as anxiety.
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Background
Traditionally, fibroblast growth factor (FGF) signal-
ing molecules are seen as crucial factors that direct the 
development of the vertebrate brain [1]. However, recent 
studies using genome-wide approaches on postmortem 
human brain tissue showed that patients suffering from 
major depressive disorder (MDD) contain significant 
alteration in FGF gene expression, when compared to 
control patients. For instance, FGF1, FGF2, FGF receptor 
(FGFR) 2 and FGFR3 were significantly down-regulated 
in the frontal cortex of MDD patients, which strongly 
suggests that FGF signaling must be disrupted in mood 
disorders [2, 3]. These data suggest that FGF function 
may not be limited to just embryonic or perinatal brain 
development, but extend well into the adult brain. Data 
from numerous clinical and basic studies have indicated 
that the hypothalamus–pituitary–adrenal (HPA) axis 
function exhibits major disruptions in affective disor-
ders during adulthood. For instance, a recent study in 
middle-aged and aged MDD patients showed higher 
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cortisol levels in the morning compared to aged control 
patients, which suggests hyperactivity of the HPA axis 
[4]. Together, these observations led us to infer that the 
FGF signaling system may play a role in the modulation 
of HPA function.
The activation of the HPA axis is controlled centrally 
by corticotropin-releasing hormone (CRH), located in 
neurons found within the parvocellular subdivision of 
the paraventricular nucleus (PVN) of the hypothalamus. 
These CRH neurons project their axons to the median 
eminence [5–9], which upon a stressful stimulus will 
release the CRH peptide into the hypophyseal portal 
vein system to stimulate pituitary adrenocorticotropic 
hormone release into the general circulation, which then 
causes the release of the adrenal glucocorticoids in order 
to maintain body homeostasis [10]. Additional stud-
ies show that vasopressin (VP) has a supportive role in 
regulating the HPA axis [11]. Indeed, VP, co-expressed 
in CRH neurons in the PVN, potentiates CRH activity 
at the level of the pituitary corticotroph within the HPA 
axis, which in turn can lead to anxiety-like behaviors [9, 
12, 13].
Recent studies using Fgf8 hypomorphic mice showed 
that the adult heterozygous (+/neo) Fgf8 hypomorphic 
mice exhibited higher levels of anxiety than their wild-
type (WT) counterparts [14, 15]. These behavioral stud-
ies were correlated with a reduction in the number of 
tryptophan hydroxylase (Tph; the rate-limiting enzyme 
for serotonin biosynthesis) expression in the dorsal raphe 
nucleus Fgf8+/neo mice when compared to WT mice 
[15]. Moreover, a follow-up study showed that the Fgf8+/
neo dorsal raphe nucleus serotonergic neurons exhib-
ited more c-FOS activation following restraint stress as 
compared to WT mice [14, 15]. Together, these studies 
showed that the adult serotonergic function was com-
promised in Fgf8+/neo mice, thus leading to the possibility 
that FGF8 has the potential to affect the normal develop-
ment of VP and CRH neurons individually.
Previous studies showed that FGF8 is a morphogen that 
regulates the normal development of the hypothalamic 
neuroendocrine cells [16–20]. For example, Fgf8+/neo and 
Fgf8neo/neo newborn mice harbor approximately 20–40 % 
less VP neurons in the PVN as compared to WT litter-
mates [16]. Similarly, FGF8 signaling was important for 
the embryonic and perinatal development of other hypo-
thalamic neuroendocrine cells, such as the oxytocinergic 
(OXT), gonadotropin-releasing hormone, and kisspeptin-
ergic neurons [16, 18–20]. However, these studies did not 
investigate whether the deficiency in FGF8 expression 
also abrogated VP and/or CRH neuronal development in 
the young and adult mouse PVN, which represents the 
central output component of the HPA-axis. To answer 
this question, we first examined the effects of a deficiency 
in FGF8 signaling on the VP and CRH neuronal popula-
tion in postnatal day PN 21 and adult PVN of Fgf8 hypo-
morphic mice. Second, we assessed whether HPA-axis 
function in adult Fgf8 hypomorphic mice was compro-




Adult 129P2/OlaHsd*CD-1 (obtained from Mouse 
Regional Resource Centers) [17] male Fgf8+/neo x female 
Fgf8+/neo mice were timed-bred in our animal facility on 
a 12L: 12D cycle with access to food and water ad  libi-
tum. All animal procedures were approved by the Insti-
tutional Animal Care and Use Committee at Kent State 
University. Postnatal day (PN) 21 and adult (6–8 weeks) 
studies were conducted in male WT or Fgf8+/neo mice. 
Fgf8neo/neo mice die shortly after birth [17, 18]. Fgf8 hypo-
morphic mice contain a neomycin-resistance element 
inserted into the non-coding region of the Fgf8 gene, 
which contains cryptic splice sites that cause an approxi-
mately 55 % reduction in functional Fgf8 mRNA levels in 
Fgf8neo/neo mice [17]. Animals were genotyped using PCR 
for Fgf8 (F5′-AAGGGAACAGAGATTTGATG-3′ and 
R5′-AGTCCACACCACCTCTCAAG-3′), and neomycin 
(N2/F2) (F5′-GATATTGCTGAAGAGCTTGGC-3′ and 
R5′-GGTCTCCACAATGAGCTTC-3′) [17].
Brain tissue collection
Brain tissue from PN 21 and adult mice were collected 
after euthanasia through decapitation, and were immer-
sion-fixed in 4  % paraformaldehyde/0.1  M phosphate 
buffer overnight and stored in 30 % sucrose prior to cor-
onal sectioning with a cryostat (Leica CM 1950, Buffalo 
Grove, IL). PN 21 and adult brain tissue was sectioned at 
45 μm in series of four.
Immunohistochemistry
Brain tissues from PN 21 (one of four series) and adult 
(one of four series) WT and Fgf8+/neo mice were simul-
taneously processed. The staining conditions were 
standardized for each of the primary antibodies. These 
measures were taken in order to minimize the variabil-
ity. Sections were incubated in 1  % hydrogen peroxide 
in TBS solution for 15  min (min) at room temperature, 
washed in TBS, 3  ×  5 min on a 2D rotator, and incu-
bated in primary rabbit polyclonal anti-CRH (1:15,000; 
PA1-37499, Thermo Fisher Scientific, Rockford, IL), rab-
bit polyclonal anti-VP (1:6000 [19, 20] ) or rabbit poly-
clonal anti-c-FOS (1:8000; Santa Cruz Biotechnologies, 
Santa Cruz, CA) diluted in TBS/0.3  % Triton-X (Fisher 
Scientific, Pittsburgh, PA) and 2 % normal goat serum for 
2 days at 4 °C. Sections were washed and incubated with 
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a biotinylated-goat anti-rabbit (1:600) for 2  h at room 
temperature followed by ABC (1:800) (Vector Laborato-
ries, Burlingame, CA) in TBS for 2  h at room tempera-
ture, and reacted with 0.05 % diaminobenzidine + 0.1 % 
nickel ammonium sulfate (Sigma-Aldrich, St. Louis, 
MO)/0.01 % H2O2 in TBS for 20 min. Following the color 
reaction, sections were dehydrated with increasing per-
centages of ethanol, and cleared with xylene prior to cov-
erslipping with DPX (Merck, Billerica, MA.)
Image analysis
VP and c‑FOS cell number
VP. Gray scale digital images of PN 21 (WT: n  =  7, 
HET: n  =  4) and adult (WT: n  =  4, HET: n  =  4) sec-
tions through the rostral-caudal extend of the PVN were 
captured using a 10 × objective mounted on a Olympus 
microscope fitted with a color camera (SC30, Olympus, 
Corporation of the Americas, Center Valley, PA) con-
nected to a PC computer. The distance between each 
immunostained section was 180  μm, which is signifi-
cantly larger than the average PVN cell size of less than 
70 μm [21]. Total number of VP-IR neurons through the 
rostral-caudal bilateral extend of the PVN was quanti-
fied manually by an investigator without knowledge of 
the genotype of the animals. Only VP-IR neurons with a 
clearly visible nuclear compartment were included in our 
analysis. These criteria increased the stringency of our 
counts, and helped minimize double counts.
c-FOS. Gray scale digital images of adult (WT: n = 4, 
HET: n = 4) sections through the rostral-caudal extend of 
the PVN were captured using a 10 × objective mounted 
on a Olympus microscope fitted with a color camera 
(SC30, Olympus, Corporation of the Americas, Center 
Valley, PA) connected to a PC computer. The distance 
between each immunostained section was 180 μm. Total 
number of c-FOS neurons through the rostral-caudal 
bilateral extend of the PVN was quantified manually by 
an investigator without knowledge of the genotype of the 
animals. Only c-FOS-IR neurons with a clearly visible 
nuclear compartment and nucleoli were included in our 
analysis. These criteria increased the stringency of our 
counts, and helped minimize double counts.
CRH density
Three rostral-caudal PN 21 (WT: n = 4, HET: n = 4) and 
adult (WT: n =  4, HET: n =  4) sections per individual 
animal, representative of the PVN, were matched using 
the fornix and optic chiasm as anatomical landmarks 
[22]. The distance between each section was 180  μm. 
These three grayscale digital images of the PVN per ani-
mal were captured using a 4 ×  objective mounted on a 
Olympus microscope fitted with a color camera (SC30, 
Olympus, Corporation of the Americas, Center Val-
ley, PA) connected to a PC computer. The images were 
analyzed with Cell Sens (Olympus Corporation of the 
Americas, Center Valley, PA). We generated a standard-
ized threshold mask which accurately covered the CRH 
immunoreactivity in WT mice. This threshold mask (PN 
21  =  179 grayscale value; adult  =  127 grayscale value) 
was then used to quantify bilaterally the CRH-IR den-
sity as immunoreactivity covered by pixels in a fixed 
rectangle (PN 21 = 567,490 μm2; adult = 470,384 μm2). 
This method was choosing because we were not able to 
reliably discern the individual CRH-IR neurons. Fur-
thermore, this method has been applied in past publica-
tions [23, 24]. Other methods of protein quantification, 
such as Western blotting, where also considered how-
ever not used for the following major reason: isolation 
and homogenization of the PVN would have meant the 
loss of precise anatomical localization of AVP and CRH 
neurons.
Restraint stress
In order to test HPA-axis responsiveness, adult male 
mice were randomly assigned to either no stress (NS) 
or restraint stress (RS) groups. Each group experienced 
the same testing procedures, except the NS mice were 
left in their cages, while the RS group were removed and 
restrained in ventilated restraint cones for 15 or 45 min.
Corticosterone enzyme‑linked immunoassay
Corticosterone levels in adult mice were measured 
immediately following 15  min of NS or RS condition 
(WT: n =  5 NS, n =  5 RS; HET: n =  5 NS, n =  5 RS) 
and 45 min of NS or RS (WT: n = 4 NS, n = 4 RS; HET: 
n =  4 NS, n =  4 RS). Their trunk blood collected into 
heparinized tubes, spun at 3000  rpm to collect plasma, 
and stored at −20 °C until the measurement of corticos-
terone levels by a commercial enzyme-linked immunoas-
say kit (ADI-900-097, Enzo Life Sciences) according to 
manufacturer’s instructions. The intra- and inter-assay 
coefficients of variation were 6.6–8.4 and 7.8–13.1  %, 
respectively, and the limit of detection was 26.99 pg/mL.
Statistical analysis
Data were analyzed for significant differences with t tests, 
one-way or two-way analysis of variance (ANOVA) with 
genotype and/or restraint stress as between subject vari-
ables. Student–Newman–Keuls tests were used for post 
hoc analysis. Differences were considered significant if 
p < 0.05. Animals and treatments were randomized and 
coded by an independent investigator. All measurements 
were conducted by an observer without knowledge of the 
genotype of the animals.
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Results
VP neurons in the PVN
Two-tailed Student t tests showed that the number of VP 
neurons did not differ between WT and Fgf8+/neo mice 
in PN 21 (Fig. 1a: t = 1.04, p = 0.33) and adults (Fig. 1b: 
t = −0.04, p = 0.97).
CRH density in the PVN
In PN 21 mice, two-tailed Student t tests showed that 
the CRH density in the PVN was significantly lower in 
WT than in Fgf8+/neo (t = −2.8, p  <  0.05) (Fig.  2i). In 
adult mice, two-tailed Student t tests showed that CRH 
density was no longer significant (t  =  0.98, p  <  0.2) 
(Fig. 2j).
Corticosteroid levels following restraint stress
Fifteen minutes. Two-way analysis of variance showed that 
RS for 15  min caused a significant increase in circulat-
ing corticosterone levels in adult WT and Fgf8+/neo mice 
(Df = 19, F = 364.5, p < 0.001). Moreover, there was a sig-
nificant main genotype effect (Df = 19, F = 5.5, p < 0.05), 
and interaction between restraint and genotype (Df = 19, 
F = 6.8, p < 0.05). Student t test analysis showed that the 
level of corticosterone was much higher in RS than NS 
WT and Fgf8+/neo mice (p < 0.001). Furthermore, elevation 
of circulating corticosterone levels after RS was higher in 
Fgf8+/neo mice than in WT mice (p < 0.003) (Fig. 3a).
Forty-five minutes. Two-way analysis of variance 
showed that RS stress for 45  min caused a significant 
Fig. 1 Photomicrographs depicting VP-IR neurons in the PVN of PN 21 a WT and b Fgf8+/neo mice, as well as adult c WT and d Fgf8+/neo mice. Scale 
bar is 200 μm. Illustrations visually show no difference between genotypes. Asterisk indicates the third ventricle. Bar graphs depicting the mean 
number of VP-IR neurons in the PVN of e PN 21 and f adult mice. The number of VP-IR neurons did not differ between WT (408.3 ± 40.4 sem) and 
Fgf8+/neo (348.5 ± 25.3 sem) mice in PN 21 or in adult WT (522.3 ± 63.9 sem) and Fgf8+/neo (525.3 ± 36.7 sem) mice
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increase in circulating corticosterone levels in adult 
WT and Fgf8+/neo mice (Df =  15, F =  24.2, p  <  0.001). 
However, there was no significant main genotypic effect 
(Df = 19, F = 0.6, p < 0.4), or interaction between stress 
and genotype (Df = 15, F = 0.5, p < 0.5). Student t test 
analysis showed that the level of corticosterone was much 
higher in RS than NS WT and Fgf8+/neo mice (p < 0.001) 
(Fig. 3b).
c‑FOS neurons in the PVN
Two-way analysis of variance showed that RS for 45 min 
caused a significant increase in the number of c-Fos-IR 
in the adult PVN in WT and Fgf8+/neo mice (Df  =  15, 
F  =  119.4, p  <  0.001). However, there was no signifi-
cant main genotypic effect (Df = 19, F = 0.56, p = 0.5), 
or interaction between restraint stress and genotype 
(Df = 19, F = 0.29, p = 0.6) (Fig. 4).
Fig. 2 Photomicrographs of CRH immunoreactivity in the PVN of PN21 a WT and b Fgf8+/neo mice, as well as adult c WT and d Fgf8+/neo mice. Scale 
bar is 200 μm. The ROI is the region of interest within which we calculated the CRH-IR density. Asterisk indicates the third ventricle. Higher magnifica-
tion photomicrographs of CRH-IR cell bodies (arrows) in PN21 e WT, f Fgf8+/neo and adult g WT, h Fgf8+/neo mice. Scale bar is 50 μm. Bar graphs repre-
sent PVN CRH-IR density converted into relative percent change compared to the WT group of i PN 21 and j adult mice. i On PN 21, CRH-IR density 
was significantly lower in WT (94.3 ± 30.6 % sem) compared to Fgf8+/neo (613.0 ± 179.8 % sem) mice. The asterisk indicates p < 0.05. j In adulthood, 
CRH-IR density did not differ between WT (99.4 ± 33.5 % sem) and Fgf8+/neo (56 ± 27.8 % sem) mice
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Discussion
Fibroblast growth factor signaling directs the develop-
ment of the vertebrate brain [1]. However, Fgf8 hypo-
morphy does not only affect neuronal development, but 
recent studies showed that abrogated FGF expression 
may have wide-spread neuropathological consequences 
during adulthood. Here, we showed that Fgf8 hypo-
morphy in young and adult mice resulted in changes in 
postnatal CRH-IR density in the PVN. We found that 
whilst the CRH-IR density in the PN 21 PVN was much 
higher in Fgf8+/neo mice than in WT mice, this geno-
type-dependent difference was absent between Fgf8+/neo 
mice and WT mice in adulthood. Moreover, in contrast 
to newborn mice, the VP-IR neuronal population in the 
PVN did not differ between WT and Fgf8+/neo mice in 
PN 21 and adulthood [16]. Interestingly, notwithstand-
ing that the VP and CRH immunoreactivity were fully 
normalized between WT and Fgf8+/neo adult mice, 
we found that adult Fgf8+/neo mice mounted a slightly 
faster, but significantly, corticosterone rise than WT 
mice in response to RS. From these observations and 
previous data, we infer that Fgf8 expression is required 
for the continued postnatal development/maturation of 
the VP and CRH neurons in the PVN, and that disrup-
tion of this process causes the adult HPA-axis in Fgf8+/
neo mice to be slightly hyper-responsive when chal-
lenged with RS.
Earlier studies found that the number of VP-IR neurons 
in the PVN was reduced in Fgf8+/neo and Fgf8neo/neo mice 
compared to WT mice [16], which may compromise 
the activation or function of the HPA axis. It has been 
well-established that Fgf8 hypomorphy causes abnormal 
apoptotic cell death during embryonic cortical and olfac-
tory placode development [25, 26], which resulted in per-
manent morphological and neurochemical changes, such 
as cortical thinning and the elimination of gonadotro-
pin-releasing hormone neurons [25–27]. Based on these 
previous data, we hypothesized that the loss of VP-IR 
neurons found in the newborn Fgf8 hypomorphic mice 
[16] was due to the elimination of embryonic PVN neu-
rons that were destined to express VP. This hypothesis 
led us to predict that the loss of VP-IR neurons in PVN 
was permanent, and therefore, would be detectable in PN 
21 and adult mice. To our surprise, the number of VP-IR 
neurons did not differ between WT and Fgf8+/neo mice 
in PN 21 or adulthood. These results led us to conclude 
that Fgf8 hypomorphy-dependent premature apoptosis in 
the PVN was not the cause for the reduced number of the 
VP-IR neurons in the newborn Fgf8 hypomorphic PVN. 
The most logical explanation is that the newborn and 
postnatal Fgf8+/neo hypomorphic PVN actually are com-
prised with a normal complement of neurons that are 
able to express VP, and that this expression is disturbed 
by the deficiency in FGF8 signaling. Previous studies 
showed that oxytocin expressing PVN neurons are simi-
larly reduced in Fgf8 hypomorphic newborn mice, which 
has been posited to be due to a disruption of the post-
translational processing of the oxytocin prohormone to 
mature oxytocin [28]. Although, this possibility may have 
caused the reduction in VP-IR neurons in the newborn 
PVN, it is far more likely that Fgf8 hypomorphy inter-
fered VP gene transcription. Indeed, in  situ hybridiza-
tion studies showed a dramatic reduction of VP mRNA 
expression in the newborn Fgf8 hypomorphic PVN [16].
Fig. 3 Bar graphs depicting corticosterone levels in adult WT and Fgf8+/neo mice in response to RS for a 15 or b 45 min. a RS for 15 min caused a 
significant rise in corticosteroid levels in WT (13.8 ± 0.8 μg/dL) and Fgf8+/neo mice (17.8 ± 1.3 sem μg/dL) compared to NS WT (0.8 ± 0.4 sem μg/
dL) and Fgf8+/neo mice (0.6 ± 0.3 sem μg/dL). The rise in corticosteroid levels after 15 min of RS was significantly lower in WT than in Fgf8+/neo mice. 
Differences in letters indicate p < 0.05. b RS for 45 min caused a significant rise in corticosteroid levels in WT (40.0 ± 2.5 μg/dL) and Fgf8+/neo mice 
(47.7 ± 16.1 sem μg/dL) compared to NS WT (2.0 ± 1.4 sem μg/dL) and Fgf8+/neo mice (1.9 ± 0.7 sem μg/dL). The rise in corticosteroid levels after 
45 min of RS did not differ between WT and Fgf8+/neo mice. Asterisk indicates p < 0.05 between animals treated with NS or RS conditions
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In contrast to the VP-IR neurons in the PVN, CRH-IR 
neuronal density in the PVN was much higher in Fgf8+/neo 
mice as compared to WT mice in PN 21, which was found 
to be fully normalized between WT and Fgf8+/neo mice in 
adulthood. These data then led us to a reinterpretation of 
the role FGF8 has in the mammalian brain. FGF8 signal-
ing may remain relevant during postnatal PVN develop-
ment and/or function. Specifically, we hypothesize that 
FGF8 signaling may regulate the timing of neuropeptide 
expression onset in postnatal PVN neurons as supported 
by the Fgf8 hypomorphy-dependent delay in VP expres-
sion and advancement of CRH expression in postnatal 
PVN neurons. Currently, more studies are required to 
fully investigate and explore the validity of this hypothesis.
Although, VP and CRH expression was normalized 
between WT and Fgf8+/neo adult mice, the rise in the 
corticosterone levels after 15 min of RS in adult Fgf8+/neo 
mice was faster than in WT mice, which was no longer 
detectable after 45  min of RS. These basic experimen-
tal studies are in line with previous behavioral stud-
ies suggesting that the HPA axis in Fgf8+/neo mice may 
be hyperactive [14, 15]. Indeed, Fgf8+/neo hypomorphic 
mice exhibited higher levels of anxiety-like behavior, 
which coincided with a reduction in the number of Tph-
expressing neurons in the dorsal raphe nucleus [15]. 
Interestingly, in a follow-up study Fgf8+/neo dorsal raphe 
nucleus serotonergic neurons exhibited more c-FOS acti-
vation following RS as compared to WT mice [14, 15]. 
These studies showed that the adult serotonergic func-
tion was compromised in Fgf8+/neo mice, which together 
with the abnormal postnatal development of the VP and 
CRH neurons in the PVN may be the underlying cause of 
Fgf8 hypomorphy-dependent HPA axis hyperactivity, and 
increased anxiety-like behaviors.
Fibroblast growth factor-dependent disruption of HPA 
function may contribute to the onset of other affective 
disorders, such as MDD. For instance, genome-wide stud-
ies in postmortem human brain tissue from patients with 
MDD showed that they harbored significant abnormali-
ties in FGF expression in the frontal cortex, when com-
pared to control patients [2, 3]. Specifically, FGF1, FGF2, 
FGF receptor (FGFR) 2 and FGFR3 were down-regulated 
in the frontal cortex of MDD patients, which strongly sug-
gests that FGF signaling must be disrupted in mood dis-
orders [2, 3]. Based on our studies showing an artificial 
partial inactivation of FGF8 signaling in the young and 
adult mouse, we postulate that FGF8 signaling may simi-
larly be involved and individuals with inactivating muta-
tions in Fgf8 may be predisposed to affective disorders.
Conclusion
Here, our studies led us to conclude that FGF8 signaling 
remains very important for the ongoing postnatal devel-
opment of the PVN in young and adult mice. First, partial 
inactivation of FGF8 signaling did not lead to the elimi-
nation of VP and CRH neurons that reside in the mouse 
PVN, but rather caused a disruption in the postnatal tim-
ing of neuropeptide expression onset in PVN neurons. 
Second, Fgf8 hypomorphy may, in part, be an explanation 
for affective disorders involving hyperactivity of the HPA 
axis, such as anxiety and MDD.
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